Signal Genetics, a predictive genetic testing company focused on oncology, recently announced that it would work with pharmaceutical company Array BioPharma to advance both companies’ goals of finding biomarkers for myeloma patients.
An disorder frequently associated with ED is Peyronie’s disease.
LifeTech Capital invites you to their 1st Annual Miami Medical Investors Conference November 12th at the brand new JW Marriott Marquis Miami.
Urovalve announced promising early results this week in a multi-site clinical trial of its Surinate Bladder Management System.
The medtech industry’s leading conference for face-to-face dialogue with top investors, large device companies, and the hottest emerging innovators.
China Analyst, a financial information website focused on U.S.-listed Chinese stocks, recently released its list of the top 10 pharmaceutical stocks with the highest upside.
The company’s lead product is Restanza (cethromycin), a novel once-a-day antibiotic for the treatment of life-threatening bacterial infections and bioterror pathogens.
There is no excerpt because this is a protected post.
There’s no better time to register to attend the Health 2.0 Fall Conference, being held October 7-8 at the Hilton San Francisco.
There is no excerpt because this is a protected post.
Copyright © 2025 | WordPress Theme by MH Themes